[주제 세부 소개]

Discover how these advanced bioactive materials synergistically redefine aesthetic facial rejuvenation. We'll explore their individual mechanisms — from deep hydration, anti-inflammatory action and collagen synthesis to cellular repair and extracellular matrix restoration. Gain insights into how combining these potent ingredients empowers unparalleled results in skin regeneration and elasticity. A must-attend for advancing your understanding and application of the latest aesthetic medicine advancements.

[연사 소개]​​

现 블루메이지 바이오테크놀리지 제약원료 영업매니저

前 해성코리아 바이오텍 영업부 팀장

[주제 세부 소개]​

Discover Holixer™, a clinically studied extract of Ocimum sanctum (Holy Basil), developed using Bioactive Optimization Technology™ (B.O.T) studied for its fast-acting benefits on stress reduction. The new Holixer sleep study on the microarchitecture of sleep showcases its impact on sleep quality, sleep efficiency and latency. Holixer™, an adaptogen, addressing two of the most pressing modern health concerns—stress and sleep—with one powerful, natural solution.

[연사 소개]​

Akrati Singh is a seasoned professional with 15 years of experience traversing the globe to source and develop innovative natural ingredients. Her journey began in the dynamic world of Specialty Chemicals, Canada, where she honed her technical expertise. Following this, she took her skills to the vibrant markets of the Middle East and Africa, focusing on cutting-edge Cosmetic Ingredients.

A blend of technical knowledge, global experience, and business!

[주제 세부 소개]

[연사 소개]

CAREGEN의 CEO 정용지 대표는 펩타이드 연구개발 분야에서 세계 최고 수준의 기술력과 다수의 특허를 보유한 글로벌 리더이다.​

[주제 세부 소개]

Newtree's exclusive partner, Fuji Oil, is a Japanese leading company that manufactures a wide range of soy ingredients.

Soy peptides will contribute to customers' product development as a beauty and health ingredient. 

[연사 소개]

Dr. Takashi Ichinose, Senior Scientist, Ph.D.

Fuji Oil Co., Ltd.

[주제 세부 소개] 

[연사 소개]

저희 마루젠 제약은 1938년의 설립되었으며 자연계의 유용 식물을 중심으로 추출 방법을 구사해, 고객의 만족, 안전성이 높은 기능성 성분을 추구해왔습니다. 이번의 화자인 야마자키는 연세 대학교 어학당을 졸업 후, 해외 영업팀 기술 영업직으로 8년에 걸쳐 한국 국내에 저희 식품 원료 , 화장품 원료를 제안하고 있습니다.​​

[주제 세부 소개]

Lipid-based excipients have emerged as key enablers in the advancement of modern drug delivery systems, offering unique physicochemical properties that make them especially suitable for complex therapeutic applications. Among their many uses, their role in the oral delivery of biopharmaceuticals has seen remarkable growth in recent years. This is particularly significant given the challenges associated with delivering biopharmaceuticals, such as insulin, which are typically large, hydrophilic, and structurally unstable molecules. These properties make them highly susceptible to enzymatic degradation and poor absorption in the gastrointestinal tract, thereby necessitating the development of robust stabilization and delivery strategies.

This presentation focuses on insulin as a model biopharmaceutical and introduces recent advances in oral delivery strategies using lipid-based approaches. In particular, it will highlight the effectiveness of specific lipid excipients in enhancing the performance of Hydrophobic Ion Pairing (HIP) technology. By forming complexes that increase the lipophilicity and stability of insulin, HIP combined with lipids represents a promising strategy to overcome traditional barriers to oral protein delivery. Case studies from recent experimental research will be presented to demonstrate the practical benefits and future potential of lipid-assisted HIP systems in biopharmaceuticals formulation. 

[연사 소개]

Professor Lee received a bachelor's degree from College of Pharmacy, Chung-Ang University in 1997, followed by a master's and Ph.D. in Pharmacy from the same institution. After completing his academic training, he gained four years of industry experience at Daewoong pharmaceutical company, where he was involved in hands-on research and development. He then held academic positions at department of pharmaceutical engineering, Inje university and College of pharmacy, Keimyung University before joining Chung-Ang University, where he currently serves as a full professor. His primary research interests focus on the brain drug delivery, cancertherapy to overcome resistant ovarian cancer, and he has conducted extensive studies on oral peptide drug delivery systems using lipid-based materials.​

[주제 세부 소개]

Besides low aqueous solubility, poor absorption is a limitation to oral efficiency for a growing number of small and large molecules, including peptides, which are also prone to degradation in the GI tract. Multifunctional lipid excipients, particularly medium-chain fatty acid esters, are emerging as promising tools to overcome these barriers.

Despite their permeation-enhancing properties being only recently elucidated, these excipients have a well-established track record in pharmaceutical development. They are present in several marketed formulations, compliant with major pharmacopeias, and manufactured by Gattefossé under responsible and sustainable practices. Their versatility allows for easy integration into both liquid and solid oral dosage forms—making them a practical and innovative solution for peptide delivery. 

[연사 소개]

PhD in Pharmaceutical Sciences, with 25 years of experience in pharmaceutical development, covering generic drugs, OTC products, veterinary medicine, pharmaceutical contract manufacturing, and prescription specialties. Career marked by responsibilities across the entire value chain, from preclinical stages to product launch, within companies such as Pierre Fabre, Ethypharm, Virbac, Sanofi, and STA Pharmaceuticals.

Since 2022, leading the Pharmaceutical Business Unit at Gattefossé, with responsibility for global innovation and commercial development of lipid-based excipients.